Tarceva News
Most Popular Tarceva Story
Tarceva successful as maintenance therapy
Genentech and OSI Pharmaceuticals today announced that a global phase III study of Tarceva--dubbed Saturn--met the primary endpoint of progression-free survival. The study, conducted by Roche, Read more...
Latest Headlines
- November 7, 2008
- July 27, 2006
- December 22, 2005
- November 2, 2005
- September 15, 2005
- September 13, 2005
- September 11, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
